ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610457 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610457; 2) Community: the network communities that were significantly associated with the response to NSC 610457; 3) Molecule: the relationships between components within communities and NSC 610457; 4) MDR: the compounds that were significantly associated with the NSC 610457.

NSC Compound Enrichment Correlation
NSC 295501 Camptothecin Derivative 0.000174252554411808 0.81837383
NSC 638436 Null 0.000193456494459355 0.52258138
NSC 11240 Aizen Victoria Blue BOH 0.000193456494459357 -0.13421754
NSC 143147 Urea, 1,1'-(methylenedi-4,1-cyclohexylene)bis[3-(2-chloroethyl)-3-nitroso- (8CI) 0.000237457299255281 0.55392437
NSC 648114 ANTINEOPLASTIC-D648114 0.000237457299255281 0.5539735
NSC 681636 Camptothecin Derivative 0.000260156221906649 0.90900366
NSC 681645 Camptothecin Derivative 0.000260156221906649 0.89617852
NSC 704533 Null 0.000260156221906649 0.68681165
NSC 724994 2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid 0.000260156221906649 0.76403154
NSC 728091 6-[(3-Hydroxy)-1-propyl]-5,6-dihydro-2,3-dimethoxy-8,9-methy lenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline 0.000260156221906649 0.64543548
Total:58  Current:1    [First] [Prev] [Next] [Last]